DOI QR코드

DOI QR Code

Guidelines for prescribing opioids for chronic non-cancer pain in Korea

  • Kim, Eung Don (Department of Anesthesiology and Pain Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Lee, Jin Young (Department of Anesthesiology and Pain Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University) ;
  • Son, Ji Seon (Department of Anesthesiology and Pain Medicine, Chonbuk National University Hospital, School of Medicine, Chonbuk National University) ;
  • Byeon, Gyeong Jo (Department of Anesthesiology and Pain Medicine, Pusan National University Yangsan Hospital, School of Medicine, Pusan National University) ;
  • Yeo, Jin Seok (Department of Anesthesiology and Pain Medicine, Kyungpook National University Medical Center, School of Medicine, Kyungpook National University) ;
  • Kim, Do Wan (Department of Anesthesiology and Pain Medicine, Kimchan Hospital) ;
  • Yoo, Sie Hyeon (Department of Anesthesiology and Pain Medicine, Soonchunhyang University Cheonan Hospital, College of Medicine, Soonchunhyang Univertisy) ;
  • Hong, Ji Hee (Department of Anesthesiology and Pain Medicine, Keimyung University Dongsan Medical Center, School of Medicine, Keimyung University) ;
  • Park, Hue Jung (Department of Anesthesiology and Pain Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • 투고 : 2016.11.28
  • 심사 : 2016.12.09
  • 발행 : 2017.01.01

초록

As the treatment of chronic non-cancer pain gradually increases, clinicians have more opportunities to encounter opioid prescription. However, guidelines for prescribing opioids for chronic non-cancer pain have never been published in Korea. The present guidelines were prepared by reviewing various research data. In cases in which the data were insufficient, recommendations were presented following discussion among experts affiliated with the Opioids Research Group in the Korean Pain Society. The present guidelines may need to be continuously revised and amended as more clinical evidence is acquired.

키워드

참고문헌

  1. Paone D, Dowell D, Heller D. Preventing misuse of prescription opioid drugs. City Health Inf 2011; 30: 23-30.
  2. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med 2005; 6: 432-42. https://doi.org/10.1111/j.1526-4637.2005.00072.x
  3. Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2--guidance. Pain Physician 2012; 15: S67-116.
  4. The Committee for the Guidelines for Prescribing Opioid Analgesics for Chronic Non-cancer Pain of JSPC. Guidelines for prescribing opioid analgesics for chronic non-cancer pain. Tokyo, Shinko Trading Press. 2012, pp 68-131.
  5. Webster LR, Dove B. Avoiding opioid abuse while managing pain: a guide for practitioners. North Branch (MIN), Sunrise River Press. 2007.
  6. Yamaguchi T, Shima Y, Morita T, Hosoya M, Matoba M; Japanese Society of Palliative Medicine. Clinical guideline for pharmacological management of cancer pain: the Japanese Society of Palliative Medicine recommendations. Jpn J Clin Oncol 2013; 43: 896-909. https://doi.org/10.1093/jjco/hyt099
  7. Hwang IC, Shim JY. Opioids use for chronic noncancer pain. J Korean Med Assoc 2013; 56: 711-7. https://doi.org/10.5124/jkma.2013.56.8.711
  8. Lee SY, Sohn KM, Ryu JY, Yoon YR, Shin JG, Kim JW. Sequence-based CYP2D6 genotyping in the Korean population. Ther Drug Monit 2006; 28: 382-7. https://doi.org/10.1097/01.ftd.0000211823.80854.db
  9. Ko Y, Kim YH. The pharmacological management of neuropathic pain. J Korean Med Assoc 2012; 55: 582-92. https://doi.org/10.5124/jkma.2012.55.6.582
  10. National Opioid Use Guideline Group (CA). Canadian guideline for safe and effective use of opioids for chronic non-cancer pain [Internet]. Ontario: Michael G. DeGroote National Pain Centre; 2010 [cited 2016 Oct 5]. Available at http://nationalpaincentre.mcmaster.ca/opioid/.
  11. Sansone RA, Sansone LA. Tramadol: seizures, serotonin syndrome, and coadministered antidepressants. Psychiatry (Edgmont) 2009; 6: 17-21.
  12. Park HJ, Moon DE. Pharmacologic management of chronic pain. Korean J Pain 2010; 23: 99-108. https://doi.org/10.3344/kjp.2010.23.2.99
  13. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009; 10: 113-30. https://doi.org/10.1016/j.jpain.2008.10.008
  14. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA 2016; 315: 1624-45. https://doi.org/10.1001/jama.2016.1464
  15. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 2005; 293: 3043-52. https://doi.org/10.1001/jama.293.24.3043
  16. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010: CD006605.
  17. Ma K, Jiang W, Zhou Q, Du DP. The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients. Int J Clin Pract 2008; 62: 241-7.
  18. Lemming D, Sorensen J, Graven-Nielsen T, Arendt-Nielsen L, Gerdle B. The responses to pharmacological challenges and experimental pain in patients with chronic whiplashassociated pain. Clin J Pain 2005; 21: 412-21. https://doi.org/10.1097/01.ajp.0000126155.82815.fc
  19. Lee WH. Use of opioid analgesics for the management of chronic noncancer pain. J Korean Pain Soc 2004; 17: S88-93. https://doi.org/10.3344/kjp.2004.17.S.S88
  20. Geppetti P, Benemei S. Pain treatment with opioids: achieving the minimal effective and the minimal interacting dose. Clin Drug Investig 2009; 29 Suppl 1: 3-16.
  21. Kahan M, Wilson L, Mailis-Gagnon A, Srivastava A; National Opioid Use Guideline Group. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations. Can Fam Physician 2011; 57: 1269-76, e419-28.
  22. Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996; 347: 143-7. https://doi.org/10.1016/S0140-6736(96)90339-6
  23. Maxwell JC. The prescription drug epidemic in the United States: a perfect storm. Drug Alcohol Rev 2011; 30: 264-70. https://doi.org/10.1111/j.1465-3362.2011.00291.x
  24. Cho YS, Lee JY, Kim HS, Kwon JH. Trends in the consumption of opioid analgesics in a tertiary care hospital from 2000 to 2012. Yakhak Hoeji 2014; 58: 268-76.
  25. Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers and other drugs among women--United States, 1999-2010. MMWR Morb Mortal Wkly Rep 2013; 62: 537-42.
  26. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011; 305: 1315-21. https://doi.org/10.1001/jama.2011.370
  27. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011; 171: 686-91.
  28. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003; 349: 1943-53. https://doi.org/10.1056/NEJMra025411
  29. Brennan MJ. The clinical implications of cytochrome p450 interactions with opioids and strategies for pain management. J Pain Symptom Manage 2012; 44: S15-22. https://doi.org/10.1016/j.jpainsymman.2012.08.012
  30. Vissers KC, Besse K, Hans G, Devulder J, Morlion B. Opioid rotation in the management of chronic pain: where is the evidence? Pain Pract 2010; 10: 85-93. https://doi.org/10.1111/j.1533-2500.2009.00335.x
  31. Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry 2013; 170: 834-51. https://doi.org/10.1176/appi.ajp.2013.12060782
  32. Degenhardt L, Bruno R, Lintzeris N, Hall W, Nielsen S, Larance B, et al. Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study. Lancet Psychiatry 2015; 2: 314-22. https://doi.org/10.1016/S2215-0366(15)00005-X
  33. Starrels JL, Becker WC, Weiner MG, Li X, Heo M, Turner BJ. Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med 2011; 26: 958-64. https://doi.org/10.1007/s11606-011-1648-2
  34. Manchikanti L, Manchukonda R, Damron KS, Brandon D, McManus CD, Cash K. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician 2006; 9: 57-60.
  35. Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain 2008; 24: 497-508. https://doi.org/10.1097/AJP.0b013e31816b1070

피인용 문헌

  1. Opioid: toward an effective strategy for better use vol.32, pp.2, 2017, https://doi.org/10.3344/kjp.2019.32.2.67
  2. Increased risk of death with codeine use in the elderly over 85 years old and patients with respiratory disease : A case-control study using retrospective insurance claims database vol.99, pp.38, 2017, https://doi.org/10.1097/md.0000000000022155
  3. Medicolegal Consideration to Prevent Medical Malpractice Regarding Opioid Administration: An Analysis of Judicial Opinion in South Korea vol.13, pp.None, 2017, https://doi.org/10.2147/jpr.s256759
  4. Patients' perception about opioids and addiction in South Korea vol.33, pp.3, 2017, https://doi.org/10.3344/kjp.2020.33.3.234
  5. Opioid Pain Medication Prescription for Chronic Pain in Primary Care Centers: The Roles of Pain Acceptance, Pain Intensity, Depressive Symptoms, Pain Catastrophizing, Sex, and Age vol.17, pp.17, 2017, https://doi.org/10.3390/ijerph17176428